Our company is mainly engaged in the production of vitaminnicotinic acid. This production has been developed from 100 tons in early days t0 600 tons today. Cefpiramide serial intermedia has been produced by 100 tons per year and other pharmaceutical intermedia 200 tons per year.
more >
Year of Establishment:
1993
Total Number of Staff:
less than 10 person
Main Competitive Advantages:
N;
Other Competitive Advantages:
Patents and Copyrights:
Business Type:
Distributor,Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Advantage Description: